"Aminolevulinic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
| Descriptor ID |
D000622
|
| MeSH Number(s) |
D02.241.755.547.276 D12.125.262
|
| Concept/Terms |
Aminolevulinic Acid- Aminolevulinic Acid
- Acid, Aminolevulinic
- Delta-Aminolevulinic Acid
- Acid, Delta-Aminolevulinic
- Delta Aminolevulinic Acid
|
Below are MeSH descriptors whose meaning is more general than "Aminolevulinic Acid".
Below are MeSH descriptors whose meaning is more specific than "Aminolevulinic Acid".
This graph shows the total number of publications written about "Aminolevulinic Acid" by people in this website by year, and whether "Aminolevulinic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2006 | 3 | 0 | 3 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aminolevulinic Acid" by people in Profiles.
-
[FALSE POSITIVE 5-ALA INDUCED FLUORESCENCE OF HEMATOLOGICAL MALIGNANCIES, BENIGN TUMORS, INFECTIOUS AND INFLAMMATORY PATHOLOGIES PRESENTED AS BRAIN LESIONS - A CASE SERIES]. Harefuah. 2023 Apr; 162(4):216-220.
-
Erosive Pustular Dermatosis of the Scalp Treated With Aminolevulinic Acid Photodynamic Therapy and Postprocedure Silicone Gel. Dermatol Surg. 2019 05; 45(5):740-743.
-
Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study. BJU Int. 2019 01; 123(1):35-41.
-
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study. J Urol. 2018 05; 199(5):1158-1165.
-
Treatment of Actinic Keratoses: A Randomized Split-Site Approach Comparison of Sequential 5-Fluorouracil and 5-Aminolevulinic Acid Photodynamic Therapy to 5-Aminolevulinic Acid Photodynamic Monotherapy. Dermatol Surg. 2017 Sep; 43(9):1170-1175.
-
Photodynamic Therapy Effectively Treats Actinic Keratoses Without Pre-Illumination Incubation Time. J Drugs Dermatol. 2017 Mar 01; 16(3):275-278.
-
Blue Light Cystoscopy Should be Used Routinely for Bladder Cancer Detection: Pro. J Urol. 2016 06; 195(6):1652-3.
-
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10):589-96.
-
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncol. 2013 Sep; 49(9):970-976.
-
Intraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: a systematic review and meta-analysis of prospective studies. PLoS One. 2013; 8(5):e63682.